Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy



Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to exercise an option to in-licence the antiviral from development partner Molecular Partners and later seek emergency use approval from U.S. regulators. Sounds great!


Read more about it


Photo Credit: Andy Holmes

8 views0 comments

Recent Posts

See All